Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Liabilities and Shareholders Equity: 2009-2024

Historic Liabilities and Shareholders Equity for Fresenius Medical Care AG (FMS) over the last 16 years, with FY2024 value amounting to $36.3 billion.

  • Fresenius Medical Care AG's Liabilities and Shareholders Equity rose 113.32% to $36.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $141.8 billion, marking a year-over-year decrease of 286.46%. This contributed to the annual value of $36.3 billion for FY2024, which is 48.22% down from last year.
  • As of FY2024, Fresenius Medical Care AG's Liabilities and Shareholders Equity stood at $36.3 billion, which was down 48.22% from $36.5 billion recorded in FY2023.
  • Fresenius Medical Care AG's Liabilities and Shareholders Equity's 5-year high stood at $37.7 billion during FY2022, with a 5-year trough of $58.0 million in FY2021.
  • For the 5-year period, Fresenius Medical Care AG's Liabilities and Shareholders Equity averaged around $22.2 billion, with its median value being $36.3 billion (2024).
  • Per our database at Business Quant, Fresenius Medical Care AG's Liabilities and Shareholders Equity plummeted by 7306.54% in 2021 and then surged by 6489880.59% in 2022.
  • Fresenius Medical Care AG's Liabilities and Shareholders Equity (Annual) stood at $215.2 million in 2020, then plummeted by 73.07% to $58.0 million in 2021, then surged by 64898.81% to $37.7 billion in 2022, then fell by 3.12% to $36.5 billion in 2023, then decreased by 0.48% to $36.3 billion in 2024.
  • Its Liabilities and Shareholders Equity was $36.3 billion in FY2024, compared to $36.5 billion in FY2023 and $37.7 billion in FY2022.